Search Results - "Manns, Kate"

‘It’s the empathy’—defining a role for peer support among people living with chronic kidney disease: a qualitative study by Elliott, Meghan J, Love, Shannan, Fox, Danielle E, Verdin, Nancy, Donald, Maoliosa, Manns, Kate, Cunningham, David, Goth, Jill, Hemmelgarn, Brenda R

“…ObjectivesPersons with advanced chronic kidney disease (CKD) have unique support needs associated with managing a chronic yet often silent condition, complex…”
Get full text

Peer Support Interventions for People With CKD: A Scoping Review by Elliott, Meghan J., Harrison, Tyrone G., Love, Shannan, Ronksley, Paul E., Verdin, Nancy, Sparkes, Dwight, O’Connor, Caitrin, Manns, Kate, Jassemi, Sabrina, Hemmelgarn, Brenda R., Donald, Maoliosa

“…Formalized peer support is a promising approach for addressing the emotional and practical needs of people living with chronic kidney disease (CKD). We…”
Get full text

The use of onabotulinumtoxinA to treat idiopathic overactive bladder in elderly patients is in need of study by Manns, Kate, Khan, Asher, Carlson, Kevin V., Wagg, Adrian, Baverstock, Richard J., Trafford Crump, R.

“…Background Injecting onabotulinumtoxinA (BoTN‐A) into the bladder has been established as an effective treatment of overactive bladder (OAB) and well‐tolerated…”
Get full text

Priorities for peer support delivery among adults living with chronic kidney disease: a patient-oriented consensus workshop by Elliott, Meghan J., Donald, Maoliosa, Farragher, Janine, Verdin, Nancy, Love, Shannan, Manns, Kate, Baragar, Brigitte, Sparkes, Dwight, Fox, Danielle, Hemmelgarn, Brenda R.

“…BACKGROUNDPeer support can address the informational and emotional needs of people living with chronic kidney disease (CKD) and enable self-management. We…”
Get full text

The Effect of Plasma Exchange on Rituximab Levels and Response to Rituximab in Patients with Acute Idiopathic Thrombotic Thrombocytopenic Pupura (TTP) by McDonald, Vickie, Scully, Marie, Mackie, Ian J., Manns, Kate, Machin, Samuel J.

“…Most cases of acute idiopathic TTP have ADAMTS13 activity <5% and detectable anti-ADAMTS13 IgG. Rituximab, a monoclonal anti-CD20 antibody, is known to be an…”
Get full text